glp-1 gastrointestinal obstruction lawsuit in michigan bowel class action Concerns have been raised about whether the delayed gastric emptying caused by GLP-1–based medications might jeopardize patient safety during Novo Nordisk is suing Eli

doi: 10.1371/journal.pone.0155694 14 CunnaneS.NugentS.RoyM.Courchesne-LoyerA.CroteauE.TremblayS.et al

These medicines mimic a natural hormone that you have in your body called GLP-1, which tells the body to release insulin (manage sugar) and reduces the amount of sugar produced by the liver, ultimately improving the bodys ability to manage blood sugar which is extremely important for people with diabetes

A short-term (90 min) stimulation with GLP-1 did not cause changes in glucose and lipid oxidation in rodent islets 15 , although, the same study reported a significant increase in glucose utilization, which perhaps has not been given sufficient attention

Prominent Driver : Heightened health awareness and an aging population are major factors behind the increased adoption of glutathione in preventive healthcare